电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant CD37 抗体

This Human 单克隆 antibody specifically detects CD37 in FACS, ELISA, Func, BLI 和 SPR. It exhibits reactivity toward 人.
产品编号 ABIN7676118
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Recombinant CD37 抗体 (ABIN7676118)

抗原

See all CD37 (TSPAN26) 抗体
CD37 (TSPAN26) (Tetraspanin 26 (TSPAN26))

抗体类型

Recombinant Antibody

适用

  • 104
  • 14
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1

宿主

  • 62
  • 39
  • 11
Human

克隆类型

  • 78
  • 31
  • 3
单克隆

标记

  • 54
  • 12
  • 10
  • 7
  • 6
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD37 antibody is un-conjugated

应用范围

  • 62
  • 33
  • 32
  • 26
  • 22
  • 9
  • 9
  • 8
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), ELISA, Functional Studies (Func), Bio-Layer Interferometry (BLI), Surface Plasmon Resonance (SPR)

克隆位点

AGS67E
  • Expression System

    CHO Cells

    原理

    Anti-TSPAN26 / CD37 Reference Antibody (AGS67E)

    产品特性

    Anti-TSPAN26 / CD37 Reference Antibody (AGS67E) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

    纯度

    >95 %

    亚型

    IgG2SA
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Lyophilized

    浓度

    1 mg/mL

    缓冲液

    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

    储存条件

    4 °C,-80 °C

    储存方法

    +4°C,-80°C
  • 抗原

    CD37 (TSPAN26) (Tetraspanin 26 (TSPAN26))

    别名

    TSPAN26

    分子量

    145.5 kDa

    UniProt

    P11049

    途径

    Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
You are here: